Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels

Biochemical and Biophysical Research Communications

Volumn 362, Issue 2, 2007, Pages 480-484

  Takeishi, Yasuchika ^a   Toriyama, Sayumi ^b   Takabatake, Noriaki ^a   Shibata, Yoko ^a   Konta, Tsuneo ^a   Emi, Mitsuru ^b   Kato, Takeo ^a   Kawata, Sumio ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b SYNEOS HEALTH   (United States)

Author keywords

BNP; NPPB; SNP

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NATRIURETIC PEPTIDE PRECURSOR B GENE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 34548259216     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.08.028     Document Type: Article

References (27)

1. Cowburn P.J., Cleland J.G., Coats A.J., and Komajda M. Risk stratification in chronic heart failure. Eur. Heart J. 19 (1998) 696-710
2. Bettencourt P., Ferreira A., and Dias P. Predictors of prognosis in patients with stable mild to moderate heart failure. J. Card. Fail. 6 (2000) 306-313
3. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N. Engl. J. Med. 339 (1998) 321-328
4. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
5. Maeda K., Tsutamoto T., Wada A., Hisanaga T., and Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am. Heart J. 135 (1998) 825-832
6. Maeda K., Tsutamoto T., Wada A., Mabuchi N., Hayashi M., Tsutsui T., et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J. Am. Coll. Cardiol. 36 (2000) 1587-1593
7. Jourdain P., Jondeau G., Funck F., Gueffet P., Helloco A.L., Donal E., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. J. Am. Coll. Cardiol. 49 (2007) 1733-1739
8. Gray I.C., Campbell D.A., and Spurr N.K. Single nucleotide polymorphisms as tools in human genetics. Hum. Mol. Genet. 9 (2000) 2403-2408
9. McCarthy J.J., and Hilfiker R. The use of single-nucleotide polymorphism maps in pharmacogenomics. Nat. Biotechnol. 18 (2000) 505-508
10. Bentley D.R. The human genome project-an overview. Med. Res. Rev. 20 (2000) 189-196
11. Cardon L.R., and Abecasis G.R. Using haplotype blocks to map human complex trait loci. Trends Genet. 19 (2003) 135-140
12. Altshuler D., Brooks L.D., Chakravarti A., Collins F.S., Daly M.J., and Donnelly P. International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
13. Konta T., Hao Z., Abiko H., Ishikawa M., Takahashi T., Ikeda A., et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int. 70 (2006) 751-756
14. Lyamichev V., Mast A.L., Hall J.G., Prudent J.R., Kaiser M.W., Takova T., Kwiatkowski R.W., Sander T.J., de Arruda M., Arco D.A., Neri B.P., and Brow M.A. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat. Biotechnol. 17 (1999) 292-296
15. Mein C.A., Barratt B.J., Dunn M.G., Siegmund T., Smith A.N., Esposito L., Nutland S., Stevens H.E., Wilson A.J., Phillips M.S., Jarvis N., Law S., de Arruda M., and Todd J.A. Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. Genome Res. 10 (2000) 330-343
16. Livak K.J. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet. Anal. 14 (1999) 143-149
17. Niizeki T., Takeishi Y., Arimoto T., Takahashi T., Okuyama H., Takabatake N., et al. A combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure. Circ. J. 69 (2005) 922-927
18. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
19. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70 (2002) 425-434
20. Hogenhuis J., Voors A.A., Jaarsma T., Hillege H.L., Boomsma F., and van Veldhuisen D.J. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur. J. Heart Fail. 7 (2005) 81-86
21. Mehra M.R., Uber P.A., Park M.H., Scott R.L., Ventura H.O., Harris B.C., et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J. Am. Coll. Cardiol. 43 (2004) 1590-1595
22. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Wilson P.W., et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 109 (2004) 594-600
23. Mir T.S., Flato M., Falkenberg J., Haddad M., Budden R., Weil J., et al. Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender. Pediatr. Cardiol. 27 (2006) 73-77
24. LaPointe M.C. Molecular regulation of the brain natriuretic peptide gene. Peptides 9 (2005) 44-56
25. Meirhaeghe A., Sandhu M.S., McCarthy M.I., Groote P.D., Cottel D., Arveiler D., et al. Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Hum. Mol. Genet. 16 (2007) 1343-1350
26. Mukoyama M., Nakao K., Saito Y., Ogawa Y., Hosoda K., Suga S., et al. Human brain natriuretic peptide, a novel cardiac hormone. Lancet 335 (1990) 801-802
27. Kosuge K., Soma M., Nakayama T., Aoi N., Sato M., Izumi Y., et al. A novel variable number of tandem repeat of the natriuretic peptide precursor B gene's 5′-flanking region is associated with essential hypertension among Japanese females. Int. J. Med. Sci. 4 (2007) 146-152